The objective of this module will be to provide knowledge and understanding of psychosis, mood disorders, eating disorders, early-life and old age psychiatry, and to appraise conventional treatments with antidepressants, dopamine-based therapies, mood stabilizers, transcranial stimulation, and cognitive/mindfulness therapies. The objective of this module will be to provide knowledge and understanding of dementias, neurodegenerative disorders, movement disorders, epilepsy, headache and chronic pain, neuro-inflammatory disorders such as multiple sclerosis, encephalopathies, and to appraise conventional treatments with anticonvulsants, deep brain stimulation, neuromodulatory treatments of movement disorders, neuromodulation surgery for pain, and pharmacogenomics for precision medicine. The objective of this module will be to afford information on molecular structures and modelling, pharmacodynamics, pharmacokinetics, principles of drug discovery, molecular cell biology underpinning drug discovery, drug metabolism, and how this knowledge with expedite drug discovery. The objective of this module will be to provide insight into available technologies and strategies for brain drug discovery including: molecular and cellular phenotypes, induced pluripotent stem cells models, single cell approaches in neurobiology, animal models, human experimental models, target discovery and validation, genome engineering.